Guidance

Hepatitis B vaccine: patient group direction template

Patient group direction (PGD) template to help provide hepatitis B vaccine to individuals before and after exposure to hepatitis B.

From:
UK Health Security Agency
Published
17 May 2017
Last updated
10 October 2023 — See all updates

Applies to England

Documents

Hepatitis B vaccine: patient group direction template

Ref: UKHSA gateway number GOV-15399

MS Word Document, 188 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the provision of hepatitis B vaccine to individuals considered at increased risk of exposure to hepatitis B virus, at increased risk of complications of hepatitis B disease, or after a potential exposure to hepatitis B virus. It may also be used to vaccinate children with incomplete or unknown immunisation status against hepatitis B.

The hepatitis B PGD version 05.00 is valid from 31 October 2023 to 30 April 2025.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine.

Published 17 May 2017
Last updated 10 October 2023 + show all updates

  1. Added version 05.00 – see page 2 for change history.

  2. Added v04.00.

  3. Added version 03.00. See page 2 for change history.

  4. Replaced PGD template with updated version.

  5. First published.

Related content